Literature DB >> 21605086

Dermatomyositis and pemphigus vulgaris: association or coincidence?

Michael Black1, Gillian Marshman.   

Abstract

A 76-year-old woman presented with a pruritic photodistributed rash and dysphagia. Serum anti-nuclear antibody was positive (titre 1/1280) and skin and muscle biopsies confirmed a diagnosis of dermatomyositis. She was treated with oral prednisolone (5-50 mg/day), mometasone furoate 0.1% ointment and lotion, and tacrolimus 0.03% ointment. Four years later she presented with multiple painful scaly erosions on the face, scalp and trunk. Histopathology and direct and indirect immunofluorescence confirmed a diagnosis of pemphigus vulgaris. Repeated malignancy screens were negative. She was treated with methotrexate (10 mg/week) and prednisolone (50 mg/day slowly tapered to 5 mg/day), with good control of both diseases.
© 2010 The Authors. Australasian Journal of Dermatology © 2010 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21605086     DOI: 10.1111/j.1440-0960.2010.00646.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

Review 1.  Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab.

Authors:  Francesco Caso; Luca Iaccarino; Silvano Bettio; Francesca Ometto; Luisa Costa; Leonardo Punzi; Andrea Doria
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 2.  Dermatomyositis in patients with autoimmune blistering diseases.

Authors:  Aikaterini Patsatsi; David R Pearson; Victoria P Werth
Journal:  Int J Womens Dermatol       Date:  2019-06-04

Review 3.  Case Report: Concurrence of Dermatomyositis and Autoimmune Blistering Diseases: Two Case Reports and a Literature Review.

Authors:  Haixi Wu; Licheng Diao; Ke Xue; Qian Zhao; Xiaoqing Zhao; Qunli Xia; Jie Zheng; Meng Pan; Hua Cao
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.